Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

VR therapy takes on stage fright in massive student trial

NCT ID NCT06593847

Symptom relief Sponsor: Boston University Charles River Campus Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tested whether one virtual reality (VR) session could help reduce public speaking anxiety in 1,542 college students. Participants gave a speech in VR after either a positive or negative mood boost. Researchers measured anxiety levels and looked at whether traits like optimism predicted better results. The goal is to understand who benefits most from VR exposure therapy for speech nerves.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
virtual reality exposure therapy
What this could lead to
If successful, this could show that a single VR session helps reduce speech anxiety, pointing toward a quick, accessible treatment option.
What could go wrong
This is a completed study, but it tests only one session and focuses on predicting outcomes, not proving long-term effectiveness. Results may not apply to everyone with speech anxiety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,542 people

The number who actually took part.

Started

Oct 2024

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Self-report of 18 - 70 years of age * Current student at a participating University * Ability to read English to provide informed consent * Familiarity with a computer keyboard and mouse or a touch screen device (e.g. phone, tablet). * For Phase 2: speech anxiety scale score of ≥ 18 on the Personal Report of Communication Apprehension, Public Speaking Subscale (PRCA-PS) Exclusion Criteria: * Previous participation (i.e., no participant may take the survey more than once).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Public speaking are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Glossophobia social phobia Speech

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Public speaking Speech anxiety

Contacts and locations

Locations

  • Albright College

    Reading, Pennsylvania, 19604, United States

  • Boston University

    Boston, Massachusetts, 02215, United States

  • Curtin University

    Bently, Western Australia, 6102, Australia

  • Erasmus University

    Rotterdam, South Holland, 3062 PA, Netherlands

  • Philipps-Universität Marburg

    Marburg, Hesse, 35037, Germany

  • Southern Illinois University

    Carbondale, Illinois, 62901, United States

  • Tufts University

    Boston, Massachusetts, 02155, United States

  • University of Arizona

    Tucson, Arizona, 85721, United States

  • University of Hong Kong

    Pokfulam, Hong Kong, China

  • University of New South Wales

    Sydney, New South Wales, 2052, Australia

  • University of Texas at Austin

    Austin, Texas, 78712, United States

  • Utrecht University

    Utrecht, 3584 CS, Netherlands

  • Western Sydney University

    Penrith, New South Wales, 2751, Australia